Cardiovascular Pharmacologic Therapies Under InvestigationCardiovascular Pharmacologic Therapies Under Investigation: 2012Frishman, William H. MD*; Pallerla, Kalyana MD†Author Information *Departments of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY †Mount Vernon Hospital/New York Medical College, Mount Vernon, NY Disclosure: The authors declare no conflict of interest. The introduction and tables of this article are a revision and an update of a chapter in Cardiovascular Pharmacotherapeutics. 3rd ed. Published by Cardiotext, Minneapolis, 2011. Correspondence: William H. Frishman, MD, Department of Medicine, New York Medical College, Munger 263, Valhalla, NY 10595. E-mail: William_Frishman@nymc.edu. Cardiology in Review: May/June 2012 - Volume 20 - Issue 3 - p 102-110 doi: 10.1097/CRD.0b013e31824c8504 Buy Metrics Abstract Cardiovascular (CV) diseases and cerebrovascular diseases remain major causes of mortality and morbidity in the United States. Intensive efforts over the past 45 years to develop important pharmacologic treatments have reduced CV risk dramatically. Described in this article are over 150 drugs being developed to prevent and treat CV disease. © 2012 Lippincott Williams & Wilkins, Inc.